Related Experiment Video
Updated: Apr 27, 2026
07:23
Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
Published on: October 20, 2023
2.0K
Physiology-based pharmacokinetic modeling: ready to be used.
Walter Schmitt1, Stefan Willmann1
1Bayer Technology Services GmbH, Competence Center Biophysics, D-51368 Leverkusen, Germany.
Drug Discovery Today. Technologies
|July 2, 2014
Summary
Physiology-based pharmacokinetic (PBPK) modeling offers a mechanistic approach to simulate drug behavior in the body. This technology is increasingly vital for accelerating drug development and enhancing regulatory efficiency.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Computational Biology
- Toxicology
Background:
- Physiology-based pharmacokinetic (PBPK) modeling is a recognized technology for simulating and predicting the disposition of xenobiotics in mammals.
- There is a growing demand for advanced methodologies in drug research and development.
Purpose of the Study:
- To highlight the increasing importance and application of PBPK modeling in the pharmaceutical industry.
- To emphasize the role of PBPK modeling in enhancing the efficiency and speed of drug development processes.
Main Methods:
- Mechanistic simulation of substance fate within a mammalian system.
- Application of PBPK modeling within the drug research and development workflow.
Main Results:
- PBPK modeling provides a mechanistic understanding of drug behavior.
- Implementation of PBPK modeling significantly contributes to faster and more efficient drug development.
Conclusions:
- PBPK modeling is a valuable tool for the pharmaceutical industry and regulatory agencies.
- Adoption of PBPK modeling accelerates drug development and improves process efficiency.
More Related Videos
Related Concept Videos
01:26Pharmacokinetic Models: Comparison and Selection Criterion
487
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
487
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
371
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
371
01:20Pharmacokinetic Models: Overview
2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
396
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
396
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
378
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
378